Filter
1904
Filtered Results: 1904
Text search:
Disruption
in
essential
health
services
Featured
Recommendations
190
New Publications
365
Language
Document type
No document type
787
Studies & Reports
513
Guidelines
233
Strategic & Response Plan
135
Manuals
123
Situation Updates
34
Fact sheets
34
Training Material
33
Brochures
4
Resource Platforms
3
Infographics
3
Online Courses
2
Countries / Regions
Global
141
Kenya
48
Liberia
45
India
44
Syria
40
Ukraine
39
Sierra Leone
37
Africa
36
Western and Central Europe
35
Myanmar / Burma
32
Nigeria
31
Nepal
29
Ethiopia
28
Latin America and the Carribbean
26
South–East Asia Region
22
Bangladesh
21
South Africa
20
Guinea
19
East and Southern Africa
18
West and Central Africa
17
Yemen
17
Malawi
16
Mozambique
16
Congo, Democratic Republic of
16
Philippines
14
Uganda
14
South Sudan
14
Ghana
13
Zambia
13
Zimbabwe
12
Haiti
12
Somalia
12
Rwanda
11
Eastern Europe
11
Namibia
11
Central African Republic
11
Afghanistan
10
Tanzania
10
Venezuela
9
Middle East and North Africa
9
Senegal
8
Western Pacific Region
8
Brazil
8
Colombia
7
Cambodia
7
Asia
7
Jordan
7
Eastern Europe and Central Asia
7
Laos
6
Vietnam
6
Pakistan
6
Thailand
5
Cameroon
5
USA
5
Lebanon
5
Guinea-Bissau
4
Germany
4
Moldova
4
Russia
4
Sudan
4
Tajikistan
3
Timor Leste/ East Timor
3
Lesotho
3
Turkey
3
China
3
Kazakhstan
3
Burkina Faso
3
Sri Lanka
3
Palestine
3
Mali
3
Chad
3
Indonesia
3
Iraq
3
Mexico
2
Chile
2
Iran
2
Canada
2
Burundi
2
Peru
2
North America
2
Turkmenistan
2
Argentina
2
Egypt
2
Bhutan
2
Botswana
2
North Korea
1
Switzerland
1
Serbia
1
Benin
1
Gambia
1
Togo
1
Singapore
1
Estonia
1
Kyrgyzstan
1
Uzbekistan
1
Hungary
1
Lithuania
1
France
1
Mauritius
1
United Kingdom
1
Portugal
1
Spain
1
Côte d’Ivoire / Ivory Coast
1
Papua New Guinea
1
Greece
1
Madagascar
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
584
Key Resources
193
Clinical Guidelines
102
Public Health
99
Women & Child Health
86
Capacity Building
36
Pharmacy & Technologies
11
Annual Report MEDBOX
1
Toolboxes
COVID-19
337
Mental Health
208
Planetary Health
131
Conflict
124
HIV
97
TB
63
Ebola & Marburg
58
Natural Hazards
57
Global Health Education
55
Refugee
48
Disability
41
Health Financing Toolbox
40
Rapid Response
38
Caregiver
33
NCDs
33
2.0 Rapid Response
31
NTDs
29
Malaria
23
AMR
23
Specific Hazards
16
Cholera
16
Pharmacy
15
Polio
8
Social Ethics
6
Zika
4
Typhoon
2
NSW Disaster Mental Health Handbook 4
The Disaster Mental Health Manual and associated handbooks are intended as a resource for mental health staff who are seeking background information and practical guidance and resources to assist in a disaster mental health response.
Since the launch of the 2012–2020 World Health Organization (WHO) road map for the control, elim-ination and eradication of neglected tropical diseases (NTDs) (1), considerable progress against NTDs has been made. Between 2010 and 2020, the number of people requiring interventions against NTDs glo...
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resistant TB (XDRTB) has also been reported from s...
Male circumcision reduces a man’s risk of heterosexual acquisition of HIV by about 60%. This guideline provides an evidence-based recommendation on the use of adult male circumcision devices for HIV prevention in public health programmes in high HIV prevalence, resource-limited settings. It also p...
Guidance on TB and TB/HIV prevention, diagnosis, treatment and care in the workplace
This report was developed by the WHO TB Vaccine Accelerator Finance and Access working group, co-led by WHO, Gavi and the Government of South Africa. It sets out the working group’s shared vision for equitable access to novel TB vaccines and will advance a shared understanding of the current lands...
Birth defects surveillance: quick reference handbook of selected congenital anomalies and infections
This Quick Reference Handbook of Selected Congenital Anomalies and Infections is a companion tool to Birth defects surveillance: a manual for programme managers, and is intended for use by front-line health care professionals who are diagnosing and collecting data on congenital defects and infection...
The first important change is a new priority ranking of the available medicines for MDR-TB treatment, based on a careful balance between expected benefits and harms. Treatment success for MDR-TB is currently low in many countries. This could be increased by improving access to the highest-ranked med...
Guide for coordinators and data collectors - The WHO Operational Package for Assessing, Monitoring and Evaluating Country Pharmaceutical Situations is intended as a useful tool for researchers, policy-makers, planners and others who need to use standardized measurement tools to gather data and other...
The World Health Organization organized a Consultation of National Leprosy Programme managers, partners and affected persons to discuss the draft Global Leprosy Strategy, 2021--2030. This virtual event took place from 26 to 30 October 2020. It was attended by more than 450 stakeholders. Contribution...
This toolkit is a comprehensive set of practical tools and resources designed to support country-level risk communication and community engagement (RCCE) practitioners, decision-makers, and partners to plan and implement readiness and response activities for yellow fever outbreaks. The toolkit conta...
Lymphatic filariasis: managing morbidity and preventing disability: an aide-mémoire for national programme managers, second edition: web annex A: protocol for evaluating minimum package of care of morbidity management and disability prevention for lymphoedema management in designated health facilit...
Module 4
Leaders
July 2017
Module 4: Leaders. This module aims to inform and update leaders and decision-makers about PrEP. It provides information on the benefits and limitations of PrEP so that they can consider how PrEP could be effectively implemented in their own settings. It also contai...
The main objective of this mission was to assess the level of preparedness of Guinea-Bissau in respect of the WHO consolidated checklist. The checklist helps countries to assess and test their level of readiness it is being used to identify concrete action to be taken and where countries will requir...
This report is primarily intended for the community of policymakers and researchers concerned about the rising risks of domestic, regional, and global infectious disease epidemics, and the collective failure to take the coordinated actions required to reduce such risks. These risks include the expec...
Health care-associated infections (HAIs) affect patients and health systems every day, causing immense suffering, driving higher health-care costs and hampering efforts to achieve high-quality care for all. HAIs are often difficult to treat, are the major driver of antimicrobial resistance (AMR) and...
The conditionality of this recommendation is largely driven by the current higher unit cost of pyrethroid-PBO ITNs compared
to pyrethroid-only LLINs and therefore the uncertainty of their cost-effectiveness. Furthermore, as PBO is less wash-resistant
than pyrethroids, its bioavailability declines ...
The guideline on Drug misuse: opioid detoxification, commissioned by NICE and developed by the National Collaborating Centre for Mental Health, sets out clear, evidence-based recommendations for healthcare staff on how to work with people who misuse opioids to significantly improve their treatment a...
The Regional strategy for measles control recommends that a second opportunity for measles immunization be provided to all children irrespective of their vaccination status or history of clinical measles. The preferred method of provision of a second opportunity is through Supplemental Immunization ...
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
